Sepehr Farahbakhshian
0000-0002-8479-2775
Publication & Citation Trends
Publications
0 total
Evaluation of clinical characteristics, health care resource utilization, and cost outcomes of hemophilia A carriers and noncarriers in the United States: A real-world comparative analysis OA
Cited by 7
Semantic Scholar
Healthcare costs among hemophilia A patients in the United States treated with rurioctocog alfa pegol (FVIII-PEG) or antihemophilic factor (recombinant), FC fusion protein (rFVIIIFc) using real-world data OA
Cited by 0
Semantic Scholar
Real‐world analysis of patients with haemophilia A and haemophilia A carriers in the United States: Demographics, clinical characteristics and costs OA
Cited by 2
Semantic Scholar
Re: Response letter to Sanofi’s communication related to “the budget impact of enzyme replacement therapy in type 1 Gaucher disease in the United States” OA
Cited by 0
Semantic Scholar
The budget impact of enzyme replacement therapy in type 1 Gaucher disease in the United States OA
Cited by 7
Semantic Scholar
Disruption of Pharmacotherapy During the Transition from Adolescence to Early Adulthood in Patients with Attention-Deficit/Hyperactivity Disorder: A Claims Database Analysis Across the USA OA
Cited by 6
Semantic Scholar
The Association of Oral Stimulant Medication Adherence with Work Productivity among Adults with ADHD OA
Cited by 4
Semantic Scholar
Economic Burden Associated with Major Surgery in Patients with von Willebrand Disease: A United States Retrospective Administrative Database Analysis OA
Cited by 4
Semantic Scholar
Research Topics
Attention Deficit Hyperactivity Disorder
(7)
Diabetes Treatment and Management
(4)
Platelet Disorders and Treatments
(4)
Hemophilia Treatment and Research
(4)
Antiplatelet Therapy and Cardiovascular Diseases
(3)
Affiliations
University of British Columbia
Takeda (United States)
AstraZeneca (United States)
Takeda (Japan)